rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Gsk Consumer Healthcare

Rediff.com  »  News  »   Gsk Consumer Healthcare

  News for Gsk Consumer Healthcare

  • Business

GSK overtakes Colgate in sensitivity segment: Nielsen

Two years after first stepping into the sensitivity toothpaste market with the launch of Sensodyne, GlaxoSmithKline Consumer Healthcare has overtaken archrival Colgate Sensitive, with a share of 26......

GlaxoSmithKline back on health track

GlaxoSmithKline Consumer has a knack of springing surprises.It posted a healthy volume growth of about nine per cent in the December 2012 quarter when most other packaged foods companies struggled......

GSK raises stake in Indian arm to 72.5%

Drug major GlaxoSmithKline Plc (GSK) has increased stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare Ltd to 72.5 per cent in a transaction worth Rs 4,800 crore (Rs 48 billion).In a......

Stay invested, more gains in the offing for GSK Consumer

The 20 per cent surge in GSK Consumer Healthcare's (GSKCH) scrip on Monday to its new 52-week high of Rs 3,651.80 was big but not surprising, given the proposed open offer by its foreign parent,......

GSK to spend $904 mn to lift stake in India arm

London-based GlaxoSmithKline on Monday announced a $940-million (Rs 5,220-crore) open offer to raise its stake in its consumer products company in India - GlaxoSmithKline Consumer Healthcare - from......
  Web results for Gsk Consumer Healthcare
Sanofi India banks on Rajaram's FMCG expertise

N Rajaram Selling shampoo is different from selling a pain killer or a drug for the central nervous system. Most in the Indian pharma industry... ...

http://businesstoday.feedsportal.com/c/33681/f/593013/s/397f91c9/sc/46/l/0Lbusinesstoday0Bintoday0Bin0Cstory0Csanofi0Eindia0Ebanks0Eon0Erajarams0Efmcg0Eexpertise0C10C20A53160Bhtml/story01.htm
NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept

/PRNewswire/ -- Today, Analysts Review released its analysts'' notes regarding Johnson & Johnson (NYSE: JNJ), Pfizer Inc. (NYSE: PFE), Merck &... ...

http://www.asianhhm.com/news/news_archives.asp?NewsID=68044&title=NDA-Filings-FDA-Approvals-Executive-Appointments-Ceased-Clinical-Trials-and-Public-OfferingsAnalyst-Notes-on-Johnson-amp-Johnson-Pfizer-Merck-GSK-and-Intercept
Ken Research

: Ken ResearchCommentsNEW DELHI, /PRNewswire/ -- Cold and Cough remedies has conventionally remained the leading segment of the industry with a... ...

http://www.andhranews.net/Intl/Web/5-59.asp
State FDA finds atorvastatin being sold at higher prices after tweaking prescribed dosage

Some of the pharmaceutical companies are understood to be selling more essential medicines at higher prices after altering the therapeutic dosages... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=81220&sid=1
Technology, Industry and Market 2014-2024

/PRNewswire/ -- Biobanks - how to find business trends, R&D, and revenue forecasts What does the future hold for medical biobanks? Now you... ...

http://in.advfn.com/p.php?pid=nmona&article=61711812

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Why I love India - Independence Day Special 2013

The Rediff Independence Day Special 2013.

The Programmer Who Came In From The Cold

Whether history will remember Edward Snowden as a traitor to his country or as a champion for...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z